Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01479725 · ClinicalTrials.gov registry record · Phase 2

Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis

A Phase 2 study, sponsored by Kenneth Peters, MD.

Completed
Registry status
Phase 2
Development phase
8
Enrollment target

NCT01479725: Completed Phase 2 study, sponsored by Kenneth Peters, MD.

NCT01479725 is a Phase 2 study that has completed, run by Kenneth Peters, MD. The registered enrollment target is 8 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01479725, a Phase 2 study, has completed, sponsored by Kenneth Peters, MD.

COMPLETED
Registry status
Phase 2
Development phase
8 participants
Enrollment target

Study Summary

To review the results of Hyperbaric Oxygen therapy (HBOT) on the symptoms of interstitial cystitis (IC). To determine if there is greater symptom improvement in the ulcerative vs the non-ulcerative patients with interstitial cystitis.

Primary Outcome

The GRA measures overall improvement with therapy. The patient's response describes their current condition compared to before they received hyperbaric oxygen therapy (HBOT). Responses are: 1 Markedly Worse, 2 Moderately Worse, 3 Mildly Worse, 4 Unchanged, 5 Mildly Better, 6 Moderately Better and 7 Markedly Better.

Interventions

  • PROCEDURE HBOT

Trial Details

FieldValue
Enrollment Target 8 participants
Start Date 2011-03
Est. Completion 2013-05
Phase Phase 2
Kenneth Peters, MD

14 total trials

What the finished NCT01479725 record still lists

NCT01479725 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which HBOT is the first listed.

NCT01479725 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01479725 about?

NCT01479725 is a clinical study titled "Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis". To review the results of Hyperbaric Oxygen therapy (HBOT) on the symptoms of interstitial cystitis (IC). To determine if there is greater symptom improvement in the ulcerative vs the non-ulcerative patients with interstitial cystitis.

What is the current status of trial NCT01479725?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 8 participants. The study started on 2011-03. Estimated completion is 2013-05.

What interventions are being tested in trial NCT01479725?

The interventions under investigation include: HBOT (PROCEDURE).

Who is sponsoring clinical trial NCT01479725?

This trial is sponsored by Kenneth Peters, MD, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01479725's enrollment target sits among peer trials

8 1990th of 2000 higher than 5 of 2,000 other Phase 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01479725, the US trial registry maintained by the National Library of Medicine. NCT01479725 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.